HealthDay (5/2, Reinberg) reports that a “survey of 72,000 Swedish adults found that 9% of women who suffered from severe tinnitus had attempted suicide, as had 5.5% of men.” But, following data analysis, “researchers found that the association between ringing ears and risk for attempted suicide was only significant for women.” The findings were published online May 2 in a research letter in JAMA Otolaryngology-Head & Neck Surgery.

Related Links:

— “‘Ringing in the Ears’ May Drive Some to the Brink of Suicide, “Steven Reinberg, Steven Reinberg, May 2, 2019

Reuters (5/2, Carroll) reports a study published in Health Psychology suggests “the stresses and emotional demands of caring for family members with dementia…can be offset by training that helps caregivers focus on the positives of their experience.” Researchers who led a “randomized, controlled trial” involving 170 dementia caregivers “showed that a six-session online training program produced modest improvements in caregiver anxiety and depression,” with participants in the intervention group experiencing “a 7 percent greater drop in depression symptoms and a 9 percent greater drop in anxiety symptoms compared with the control group.”

Related Links:

— “Happiness training may ease dementia caregivers’ anxiety, depression, “Linda Carroll, Reuters, May 2, 2019

The New York Times (5/2, Bakalar) reports, “Girls who have serious or repeated infections in childhood are at higher risk for developing eating disorders in adolescence,” researchers concluded after tracking “525,643 girls – every girl born in Denmark from 1989 through 2006” – and recording “all prescriptions that were filled for antibiotics and other anti-infective medications, as well as hospitalizations for infection, through 2012. There were 4,240 diagnoses of eating disorders during that time.” The findings were published online April 24 in JAMA Psychiatry.

Related Links:

— “Anti-Infective Drugs Tied to Eating Disorders, “Nicholas Bakalar, The New York Times, May 2, 2019

Stateline (5/1, Vestal) reports that it is “increasingly likely that someone you know has the opioid overdose rescue drug naloxone in their pocket or medicine cabinet,” and “in the last five years, at least 46 states and the District of Columbia enacted so-called good Samaritan laws, allowing private citizens to administer the overdose-reversal medication without legal liability.” But, Stateline notes, “a handful of states are going even further by requiring doctors to give or at least offer a prescription for the overdose rescue drug to patients taking high doses of opioid painkillers.”

Related Links:

— “New Naloxone Laws Seek to Prevent Opioid Overdoses, “Christine Vestal, Stateline, May 01, 2019

Recent reports show a small but growing number of people are taking very high doses of loperamide, an anti-diarrheal medication, in an attempt to self-manage opioid withdrawal or to achieve a euphoric high. At high doses, these individuals may be at risk of severe or fatal cardiac events. Learn more about identifying patients at risk of misusing loperamide at LoperamideSafety.org

Related Links:

— Understanding Loperamide Abuse

Bloomberg (4/30, Cortez) reports the Food and Drug Administration will now require a boxed warning on certain prescription sleeping medications, including Ambien (zolpidem), Lunesta (eszopiclone), and Sonata (zaleplon), advising patients about the risk of serious side effects that can lead to death. The article explains that the agency “said it had found 66 examples of patients who took the drugs and engaged in dangerous activities such as sleepwalking or driving while not fully awake, including 20 deaths linked to carbon monoxide poisoning, drowning, fatal falls, hypothermia, car crashes and apparent suicide.”

CNN (4/30, Scutti) reports the boxed warning will notify “patients to possible serious or life-threatening behaviors that may result from taking these drugs.”

Related Links:

— “Sleeping-Pill Deaths Prompt FDA to Add Strict Warning for Drugs, “Michelle Cortez, Bloomberg, April 30, 2019

Psychiatric News (4/30) reports, “Suicide deaths increased in the 30-day period following the suicide of Robin Williams on August 11, 2014,” researchers concluded. For the study, investigators analyzed “data from the National Center for Health Statistics” and “compared U.S. daily suicides in the 30 days before and after August 11, 2014, as well as for the same periods in 2012 and 2013.” The study revealed that “suicide deaths were between 113 and 117 a day for the 30 days before Williams’ death but increased to 142 a day in the 30-day period beginning August 12.” The findings were published online April 30 in Psychiatric Services.

Related Links:

— “Suicide Deaths, Calls to Hotlines Increased Dramatically Following Robin Williams’ 2014 Suicide, Psychiatric News , April 30, 2019

The AP (4/30, Neergaard) reports that “some people told they have Alzheimer’s may instead have a newly identified mimic of the disease.” It is unclear “how many people have this particular type” of dementia, “which an international team of scientists defined Tuesday in the journal Brain.”

CNN (4/30, Nedelman) reports, “The disease, called LATE, may often mirror the symptoms of Alzheimer’s disease, though it affects the brain differently and develops more slowly than Alzheimer’s.” According to CNN, “The acronym LATE stands for limbic-predominant age-related TDP-43 encephalopathy.” This “full name refers to the area in the brain most likely to be affected, as well as the protein at the center of it all.”

HealthDay (4/30, Norton) reports that “LATE mainly affects people older than 80, the experts explained.” HealthDay adds that “it may account for about 17% of all cases of dementia.”

Also covering the story are The Guardian (UK) (4/30, Devlin), BBC News Online (UK) (4/30, Roberts), the Telegraph (UK) (4/30, Knapton), MedPage Today (4/30, George), and Science News (4/30, Sanders).

Related Links:

— “It seems like Alzheimer’s but peek into brain shows a mimic, “LAURAN NEERGAARD, AP, April 30, 2019

The Wall Street Journal (4/29, Subscription Publication) reports the Centers for Medicare and Medicaid Services is considering a rule which would mandate that drug companies show the list prices of prescription medications while advertising the drugs on television. Although the proposed rule is largely supported by consumers, the pharmaceutical industry opposes it, partly because list prices often do not reflect what consumers typically pay for the drugs after rebates and insurance.

Related Links:

— “Should Drug Prices Be Disclosed in Ads Targeted Directly to Consumers?,, April 29, 2019

CNN (4/29, Howard) reports findings from a study of 1,300 toddlers “suggest that autism detection and diagnosis can start as young as 14 months old with high accuracy, which could lead to children with autism having the option to start therapies early.” The findings were published in JAMA Pediatrics.

HealthDay (4/29, Gordon) reports “the study found that 84% of those diagnosed early still met the criteria for having an autism spectrum disorder when they were re-evaluated at 3 years of age,” while “the remaining 16% thought to have an autism spectrum disorder early in life, most were later found to have a language or other developmental delay.”

The San Diego Union-Tribune (4/29) reports “if results are confirmed by independent research, this would be the earliest age this has proven feasible.” The study was “funded in part, by the National Institute of Mental Health.”

Related Links:

— “When to screen for autism? New study suggests as young as 14 months, “Jacqueline Howard, CNN, April 29, 2019